Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings !
Welcome to yet another most pleasant Reading of our newsletter.
Please do not hesitate to mail your comments on this edition to help us further improve so please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
"Quad is more than just a security mechanism. Rather, the arrangement — not a coalition, not a partnership, not an alliance — has larger goals. There is a positive agenda here. When the Quad foreign ministers had their interaction... there was a broader touch on being political democracies, market economies, pluralistic societies, and that they will work together on those issues besides a rulesbased international order."
Mr. Taranjit Singh Sandhu
Indian Ambassador,
Washington DC, USA
Government of India
Sponsor
Patient Safety Capsules
PM's Picture Excluded From Covid-19 Vaccine Certificates In Poll-Bound States: Sources
New Delhi, 11 March 2021: The Union Health Ministry has applied filters in its Co-Win platform in poll-going states and a union territory to exclude the picture of the prime minister from the Covid-19 vaccine certificates, sources said on Thursday. In a letter to the Election Commission on March 9, Union Health Secretary Rajesh Bhushan is learnt to have said that "technical measures to comply with the directions of EC have been explored promptly."
112 Research Studies In The Country Are Being Conducted On AYUSH Interventions As Prophylactic Interventions
New Delhi, 12 Feb 2021 (PTI): New Delhi, 9 March 2021: Ministry of AYUSH has formed an Inter-disciplinary AYUSH R&D Task Force chaired by Prof. Bhushan Patwardhan and having representation from scientists including Indian Council of Medical Research (ICMR), Department of Biotechnology(DBT), Council of Scientific and Industrial Research (CSIR), All India Institute of Medical Sciences (AIIMS) and AYUSH Institutions.
Drug Laws & Policy Injections
Anti-Dumping Duty Imposed On Chinese Ciprooxacin HydrochlorideNew Delhi, 13 March 2021: India has imposed anti-dumping duty on the Chinese antibacterial drug Ciprofloxacin Hydrochloride to guard the domestic industry against cheap imports from the neighbouring country. The duty was imposed following a recommendation by the commerce ministry's investigation arm Directorate General of Trade Remedies (DGTR).
Germany, France, Canada & Oz Say Astra Vaccine Is Safe Berlin, 13 March 2021: Officials in several European countries, along with Canada and Australia, pushed back on Friday against decisions by others to pause use of AstraZeneca’s Covid-19 vaccine following sporadic reports of blood clots, despite a lack of evidence that the shot was responsible.
Novavax Shot 96% Effective Against Covid In Final StudyWashington, 13 March 2021: US-based Novavax on Friday announced a final efficacy figure of 96.4% for its vaccine against the original strain of the novel coronavirus, with an efficacy as high as 83.4% two weeks after the first shot itself, boosting the global fight against covid-19.
WHO Encourages All Nations To Closely Monitor Adverse Effects Of Any Vaccine In UseGeneva, 12 March 2021: All countries should closely monitor adverse health effects related to the use of any vaccine, a spokesperson for the World Health Organization (WHO) told Sputnik following the suspension of the AstraZeneca drug in several EU countries.
'No Evidence' Of Blood Clot Risk From Vaccine: AstraZenecaLondon, 13 March 2021 (ANI): AstraZeneca, on Friday defended its vaccine saying that there was "no evidence of an increased risk" of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed and that rollouts should continue.
India To Produce J&J Shot As Part Of Quad InitiativeNew Delhi, 12 March 2021: India will manufacture the US-developed Johnson & Johnson’s single-dose Covid shot as part of the first Quad vaccine initiative. The project will be financed by Japan and the US, while Australia will use its logistics capability to ship the vaccines to Southeast Asia and Pacific countries.
Pharma Injections
Gastrointestinal Obstructions New Covid SymptomsMumbai, 13 March 2021: City doctors have seen Covid-19 patients with newer and unusual symptoms, some not related to the respiratory system at all. Most, though, could be managed with conservative Covid treatment when detected early.
InStem And Curie Institute Scientists Develop Molecular Sensor To Detect Cancer DrugsMumbai, 12 March 2021: The Institute for Stem Cell Science and Regenerative Medicine (InStem), Bengaluru in collaboration with Curie Institute, Orsay, France, has developed a molecular sensor, which can identify cancer drugs by detecting how such chemicals modify microtubules inside living cells.
DCC Emphasizes Need To Regulate Sale And Distribution Of Medical Devices Bengaluru, 11 March 2021: The Drugs Consultative Committee (DCC) has underlined the need to regulate sale and distribution of medical devices mandating registration of retail and distributor premises. This, according to the Committee, will bring in transparency of the sales outlets and provide credibility to the product safety.
Curb Covid-19 Vaccine Wastage, Cross-Selling By Private Hospitals, Centre Tells States New Delhi, 10 March 2021: The Centre has asked states to curb wastage of vaccines to avoid the creation of a black market in the future, curb cross-selling of products by private hospitals to people who come for vaccination, and to focus on resolving scheduling and other implementation issues including issuing of digital certificates for those vaccinated.
CAG Report On Uttarakhand Hospitals: Inoperative ICUs, X-Ray Machines Without License Dehradun, 10 March 2021: A report filed by the Comptroller and Auditor General of India (CAG) on the outcomes of Uttarakhand’s district hospitals covering the period 2014-19, which was tabled in the state Assembly on Saturday, has been extremely critical of the state-run institutions, pointing to a lack of operation theatres for emergency surgeries and inoperative ICU facilities, X-ray machines running without license, and of ambulances running without fitness or pollution certificates, among other shortcomings.
AstraZeneca Pharma Gets DCGI Nod For Lung Cancer Treatment Drug New Delhi, 10 March 2021: AstraZeneca Pharma India on Wednesday said it has received marketing approval from the Drugs Controller General of India (DCGI)for its product for the treatment of non-small cell lung cancer.
Drug Dopes
Entry Of PCDs In CIPMMA Will Lead To Corruption: SA ManikantanChennai, 10 March 2021: Even as the dispute between two factions of the Consortium of Indian Pharmaceutical Marketers and Manufacturers Associations (CIPMMA) over membership for propaganda-cum-distributors (PCDs) in the consortium is continuing without settlement, a leading marketing company leader in Chennai has opined that it is dangerous to allow PCDs into the association of marketing companies. 
CDSCO Directs For E-Submission Of Applications For Veterinary VaccinesMumbai, 9 March 2021: In order to streamline the regulatory submission procedure, the Central Drugs Standard Control Organisation (CDSCO) has directed all State Licensing Authorities (SLAs) and manufacturers for online submission of applications for issuance of Form 41 (Registration Certificate) and Form 10 (Import License) for veterinary vaccines through Sugam portal.
Indian Pharma Market Growth Slips To 1.1% In February 2021 Mumbai, 9 March 2021: The Indian Pharmaceutical Market (IPM) has registered a growth of 1.1% for the month of February 2021, after registering a growth of 4.5% for the month of January 2021.
Lancet Publishes Covaxin Phase 2 Trials Data HYDERABAD, 9 MARCH 2021: A week after Bharat Biotech and Indian Council of Medical Research (ICMR) announced that India’s first indigenous Covid-19 vaccine Covaxin, (codenamed BBV152) has shown an interim efficacy of nearly 81%, prestigious medical journal The Lancet has now published Phase 2 clinical trial results of the vaccine candidate.
Maha FDA Writes To Central Govt Asking It To Cap Remdesivir Rate Mumbai, 7 March 2021: With cases surging in the state, the Maharashtra Food and Drugs Administration (FDA) is working to bring down cost of the remdesivir injection, used for treating critical Covid-19 cases.
Bhubaneswar Gets Common Facility Center For Pharmaceutical ClusterBHUBANESWAR, 7 MARCH 2021: A Common Facility Center (CFC) for Pharmaceutical Cluster (Cuttack-Bhubaneswar) was inaugurated by Union minister of state for MSME Pratap Chandra Sarangi in Mancheswar Industrial area here on Sunday. It will work as a testing and training facility for pharmaceutical units in the state.
National Injections
IMPCL Ties Up With Government E-Market Portal To Sell Its Products Online Mumbai, 9 March 2021: The Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Union Ministry of Ayush, has tied up with the government e-market (GeM) portal for selling its products online.
DCGI Urged To Not Accept Data From "Discredited Test" For Depression DrugsMumbai, 7 March 2021: A “near drowning” test that uses small animals in the testing for depression and mood disorder drugs has come in for criticism, with pro-animal groups approaching the Drug Controller General of India (DCGI). The test that has been stopped by some international pharmaceutical companies.
No Recognition For Electropathy Courses: Min Jaipur, 5 March 2021: Medical and Health Minister Raghu Sharma in assembly said in reply that neither any institution is affiliated with the state government nor recognition has been given for conducting electropathy courses in the state under Rajasthan Electropathy Systems of Medicines Act, 2008.
DCGI Sub-Committee Submits Guidelines On Post-Approval Changes In Drugs Mumbai, 5 March 2021: The sub-committee, constituted by the Drugs Controller General of India (DCGI), has submitted the guidelines on post-approval changes in drugs to the Union Health Ministry which are today very important from the standpoint of global regulatory harmonisation.
SII Writes To PMO Proposing Reforms In Drug Regulatory System New Delhi, 4 March 2021: The world's largest vaccine manufacturer by volume, Serum Institute of India, has written to the Prime Minister's Office proposing reforms in the existing drug regulatory system, including allowing manufacturing and stockpiling of non-COVID vaccines while undergoing clinical trial.
Sub-Committee On FDCs To Hear Stakeholders From April 19 Mumbai, 8 March 2021: The sub-committee, constituted for examining the fixed dose combinations (FDCs) considered as irrational by Prof Kokate Committee, has invited concerned stakeholders for hearing from April 19, 2021.
Global Injections
Pfizer Vaccine Neutralises Brazil Variant In Lab StudyNew York, 10 March 2021: The Covid-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralise a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday.
Covid Survivors May Suffer Cognitive ComplicationsLondon, 6 March 2021: A large proportion of Covid-19 survivors may be affected by neuropsychiatric and cognitive complications, say researchers, including one of Indian-origin.
US FDA Warns Against Using Ivermectin For Covid-19 After Reports Of Hospitalizations
Washington, 5 March 2021: The US Food and Drug Administration on Friday said that people should not use ivermectin to attempt to treat or prevent Covid-19. The drug is typically used to treat parasites, such as lice and scabies.
COVID-19 Can Kill Heart Muscle Cells, Interfere With Contraction
St. Louis, 2 March 2021: Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ability to pump blood and abnormal heart rhythms. But it's been an open question whether these problems are caused by the virus infecting the heart, or an inflammatory response to viral infection elsewhere in the body. Such details have implications for understanding how best to treat coronavirus infections that affect the heart.
US FDA Approves Emergency Use Of J&J Covid-19 Vaccine
New York, 28 Feb 2021: The US Food and Drug Administration (FDA) has approved the single-shot Johnson and Johnson (J&J) Covid-19 vaccine for emergency use, the third to be authorised against the disease in the country.
7 Pharma Barons In 10 From Hyderabad In Global Billionaire Club
Hyderabad, 3 March 2021: As many as 10 billionaires from Hyderabad, seven being pharma barons, have made it to Hurun Global Rich List 2021 with a cumulative wealth of nearly $23 billion (Rs 1,65,900 crore).
PSAIIF PILL
Govt Working On Formulating Standards For AYUSH Products
New Delhi, 8 March 2021: The government is working on formulation of standards for AYUSH (Ayurveda, Yoga, Unani, Siddha and Homoeopathy) products with an aim to augment its international trade by ensuring quality of goods and services, an official said.
HC Asks Delhi Govt To Comply With Order To Regulate Online Path Labs Or Else Face Action
New Delhi, 5 March 2021: The Delhi High Court Friday said it expects that the AAP government will put things in order and comply with a judicial order asking authorities to take action and regulate online pathological labs, otherwise contempt action would be initiated. The high court, which was hearing a plea alleging non-compliance of its order in this regard, also sought to know from the AAP government whether its pathological laboratories and hospitals are NABL accredited.
Frequently Asked Questions
On Guidelines For Pharma PLI Scheme To Be Out By March? : Secy
New Delhi, 26 Feb 2021: The Centre is likely to announce guidelines for the ₹15,000 crore production-linked incentive (PLI) scheme for the pharma sector in March, pharma secretary S. Aparna said on Thursday.Read More>>>
SUBSCRIBER'S SYMPTOM
Gujarat FDCA Introduces Online Facility For CoPP With QR Code
Mumbai, 1 March 2021: In order to streamline the process of issuance of WHO-GMP Certification Scheme for Certificate of Pharmaceutical Products (CoPP) through online mode to boost exports, the Gujarat Food and Drug Control Administration (FDCA) has introduced online facility for submission of applications for WHO-GMP CoPP with QR Code for first time in country through its DMLA software.
Blog Addicts
Ms Deep Jyoti Pande, Professional The Prescription has articles that make very good reading. Excellent presentation. Well done.
Dr Vasudev Sarangi, MDThe Newsletter has extremely useful information for readers. Great reading, please continue.
Mr Hem Raj Tandon, Pharma Expert
Good newsletter which brings an array of Pharma News for the avid Prescription newsletter. Keep up the good work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
